{"entity":{"type":"insider","cik":"0001599743","url":"/insider/0001599743","json_url":"/insider/0001599743.json","name":"Krill Steven L.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":5,"first":"2015-06-18","last":"2017-03-24","span_basis":"filed_date"},"name_variants":[{"name":"Krill Steven L.","source":"filing","n_filings":5,"first_seen":"2015-06-18","last_seen":"2017-03-24"}],"transactions":[{"id":5172293,"accession":"0001209191-17-022772","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-17-022772","line_url":"/filing/0001209191-17-022772#line-6","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001599743","owner_name":"Krill Steven L.","owner_display_name":"Krill Steven L.","owner_url":"/insider/0001599743","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7025.0,"shares_display":"7,025","price_per_share":82.0625,"price_display":"82.06","price_state":"stated","total_value":576489.0625,"total_display":"576,489.06","total_whole":"576,489","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-23","filed_date":"2017-03-24","scope":"insider"},{"id":5172279,"accession":"0001209191-17-022772","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-022772","line_url":"/filing/0001209191-17-022772#line-3","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001599743","owner_name":"Krill Steven L.","owner_display_name":"Krill Steven L.","owner_url":"/insider/0001599743","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7100.0,"shares_display":"7,100","price_per_share":80.0903,"price_display":"80.09","price_state":"stated","total_value":568641.13,"total_display":"568,641.13","total_whole":"568,641","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-22","filed_date":"2017-03-24","scope":"insider"},{"id":4970307,"accession":"0001209191-17-001510","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001209191-17-001510","line_url":"/filing/0001209191-17-001510#line-18","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001599743","owner_name":"Krill Steven L.","owner_display_name":"Krill Steven L.","owner_url":"/insider/0001599743","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5127.0,"shares_display":"5,127","price_per_share":78.6069,"price_display":"78.61","price_state":"stated","total_value":403017.5763,"total_display":"403,017.58","total_whole":"403,018","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-23","filed_date":"2017-01-04","scope":"insider"},{"id":4970299,"accession":"0001209191-17-001510","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001209191-17-001510","line_url":"/filing/0001209191-17-001510#line-16","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001599743","owner_name":"Krill Steven L.","owner_display_name":"Krill Steven L.","owner_url":"/insider/0001599743","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5126.0,"shares_display":"5,126","price_per_share":76.7794,"price_display":"76.78","price_state":"stated","total_value":393571.2044,"total_display":"393,571.20","total_whole":"393,571","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-22","filed_date":"2017-01-04","scope":"insider"},{"id":4970281,"accession":"0001209191-17-001510","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001209191-17-001510","line_url":"/filing/0001209191-17-001510","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001599743","owner_name":"Krill Steven L.","owner_display_name":"Krill Steven L.","owner_url":"/insider/0001599743","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10252.0,"shares_display":"10,252","price_per_share":77.1747,"price_display":"77.17","price_state":"stated","total_value":791195.0244,"total_display":"791,195.02","total_whole":"791,195","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-21","filed_date":"2017-01-04","scope":"insider","n_lines":2},{"id":4970266,"accession":"0001209191-17-001510","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-17-001510","line_url":"/filing/0001209191-17-001510#line-10","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001599743","owner_name":"Krill Steven L.","owner_display_name":"Krill Steven L.","owner_url":"/insider/0001599743","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":76.6876,"price_display":"76.69","price_state":"stated","total_value":766876.0,"total_display":"766,876.00","total_whole":"766,876","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-20","filed_date":"2017-01-04","scope":"insider"},{"id":4970255,"accession":"0001209191-17-001510","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-17-001510","line_url":"/filing/0001209191-17-001510","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001599743","owner_name":"Krill Steven L.","owner_display_name":"Krill Steven L.","owner_url":"/insider/0001599743","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":75.6066,"price_display":"75.61","price_state":"stated","total_value":756066.0,"total_display":"756,066.00","total_whole":"756,066","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-19","filed_date":"2017-01-04","scope":"insider","n_lines":2},{"id":4970234,"accession":"0001209191-17-001510","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-001510","line_url":"/filing/0001209191-17-001510","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001599743","owner_name":"Krill Steven L.","owner_display_name":"Krill Steven L.","owner_url":"/insider/0001599743","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":74.7896,"price_display":"74.79","price_state":"stated","total_value":747896.0,"total_display":"747,896.00","total_whole":"747,896","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-15","filed_date":"2017-01-04","scope":"insider","n_lines":2},{"id":2257301,"accession":"0001209191-16-155448","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-155448","line_url":"/filing/0001209191-16-155448#line-2","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001599743","owner_name":"Krill Steven L.","owner_display_name":"Krill Steven L.","owner_url":"/insider/0001599743","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":73.6163,"price_display":"73.62","price_state":"stated","total_value":736163.0,"total_display":"736,163.00","total_whole":"736,163","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-13","filed_date":"2016-12-15","scope":"insider"},{"id":3326773,"accession":"0001209191-16-153187","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-16-153187","line_url":"/filing/0001209191-16-153187","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001599743","owner_name":"Krill Steven L.","owner_display_name":"Krill Steven L.","owner_url":"/insider/0001599743","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5787.0,"shares_display":"5,787","price_per_share":80.0,"price_display":"80.00","price_state":"stated","total_value":462960.0,"total_display":"462,960.00","total_whole":"462,960","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-30","filed_date":"2016-12-02","scope":"insider","n_lines":3},{"id":3326747,"accession":"0001209191-16-153187","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-153187","line_url":"/filing/0001209191-16-153187#line-2","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001599743","owner_name":"Krill Steven L.","owner_display_name":"Krill Steven L.","owner_url":"/insider/0001599743","role":"Officer (EVP & Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":80.0,"price_display":"80.00","price_state":"stated","total_value":16000.0,"total_display":"16,000.00","total_whole":"16,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-23","filed_date":"2016-12-02","scope":"insider"},{"id":8675136,"accession":"0001209191-15-054843","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-15-054843","line_url":"/filing/0001209191-15-054843","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":"0001599743","owner_name":"Krill Steven L.","owner_display_name":"Krill Steven L.","owner_url":"/insider/0001599743","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9980.0,"shares_display":"9,980","price_per_share":81.6,"price_display":"81.60","price_state":"stated","total_value":814368.0,"total_display":"814,368.00","total_whole":"814,368","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-16","filed_date":"2015-06-18","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000827871","name":"EAGLE PHARMACEUTICALS, INC.","url":"/issuer/0000827871","role":"Officer (EVP & Chief Scientific Officer)","n_filings":5,"first_seen":"2015-06-18","last_seen":"2017-03-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001599743","retrieved_at":"2026-08-27T12:16:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}